Global Imatinib Drug Market Insights, Forecast to 2025

Choose Licence

Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.

Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth. 
The global Imatinib Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Imatinib Drug market based on company, product type, end user and key regions.

This report studies the global market size of Imatinib Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Imatinib Drug in these regions.
This research report categorizes the global Imatinib Drug market by top players/brands, region, type and end user. This report also studies the global Imatinib Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Novartis
    Glenmark Pharmaceuticals Ltd.
    Sun Pharmaceuticals
    Actavis Generics
    Dr. Reddy's Laboratories
    Teva Pharmaceutical Industries Ltd.
    Sanofi S.A.
    Cipla Inc.
    Apotex Inc.
    Mylan Pharms Inc.

Market size by Product
    Tablets
    Capsules
Market size by End User
    Chronic myelogenous leukemia
    Gastrointestinal stromal tumors
    Others

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Imatinib Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Imatinib Drug market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Imatinib Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Imatinib Drug submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Imatinib Drug are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Imatinib Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1  Imatinib Drug Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Imatinib Drug Market Size Growth Rate by Product
        1.4.2 Tablets
        1.4.3 Capsules
    1.5 Market by End User
        1.5.1 Global Imatinib Drug Market Size Growth Rate by End User
        1.5.2 Chronic myelogenous leukemia
        1.5.3 Gastrointestinal stromal tumors
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Imatinib Drug Market Size
        2.1.1 Global Imatinib Drug Revenue 2014-2025
        2.1.2 Global Imatinib Drug Sales 2014-2025
    2.2 Imatinib Drug Growth Rate by Regions
        2.2.1 Global Imatinib Drug Sales by Regions
        2.2.2 Global Imatinib Drug Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Imatinib Drug Sales by Manufacturers
        3.1.1 Imatinib Drug Sales by Manufacturers
        3.1.2 Imatinib Drug Sales Market Share by Manufacturers
        3.1.3 Global Imatinib Drug Market Concentration Ratio (CR5 and HHI)
    3.2 Imatinib Drug Revenue by Manufacturers
        3.2.1 Imatinib Drug Revenue by Manufacturers (2014-2019)
        3.2.2 Imatinib Drug Revenue Share by Manufacturers (2014-2019)
    3.3 Imatinib Drug Price by Manufacturers
    3.4 Imatinib Drug Manufacturing Base Distribution, Product Types
        3.4.1 Imatinib Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Imatinib Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Imatinib Drug  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Imatinib Drug Sales by Product
    4.2 Global Imatinib Drug Revenue by Product
    4.3 Imatinib Drug Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Imatinib Drug Breakdown Data by End User

6 North America
    6.1 North America Imatinib Drug by Countries
        6.1.1 North America Imatinib Drug Sales by Countries
        6.1.2 North America Imatinib Drug Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Imatinib Drug by Product
    6.3 North America Imatinib Drug by End User

7 Europe
    7.1 Europe Imatinib Drug by Countries
        7.1.1 Europe Imatinib Drug Sales by Countries
        7.1.2 Europe Imatinib Drug Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Imatinib Drug by Product
    7.3 Europe Imatinib Drug by End User

8 Asia Pacific
    8.1 Asia Pacific Imatinib Drug by Countries
        8.1.1 Asia Pacific Imatinib Drug Sales by Countries
        8.1.2 Asia Pacific Imatinib Drug Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Imatinib Drug by Product
    8.3 Asia Pacific Imatinib Drug by End User

9 Central & South America
    9.1 Central & South America Imatinib Drug by Countries
        9.1.1 Central & South America Imatinib Drug Sales by Countries
        9.1.2 Central & South America Imatinib Drug Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Imatinib Drug by Product
    9.3 Central & South America Imatinib Drug by End User

10 Middle East and Africa
    10.1 Middle East and Africa Imatinib Drug by Countries
        10.1.1 Middle East and Africa Imatinib Drug Sales by Countries
        10.1.2 Middle East and Africa Imatinib Drug Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Imatinib Drug by Product
    10.3 Middle East and Africa Imatinib Drug by End User

11 Company Profiles
    11.1 Novartis
        11.1.1 Novartis Company Details
        11.1.2 Company Business Overview
        11.1.3 Novartis Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Novartis Imatinib Drug Products Offered
        11.1.5 Novartis Recent Development
    11.2 Glenmark Pharmaceuticals Ltd.
        11.2.1 Glenmark Pharmaceuticals Ltd. Company Details
        11.2.2 Company Business Overview
        11.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Products Offered
        11.2.5 Glenmark Pharmaceuticals Ltd. Recent Development
    11.3 Sun Pharmaceuticals
        11.3.1 Sun Pharmaceuticals Company Details
        11.3.2 Company Business Overview
        11.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Sun Pharmaceuticals Imatinib Drug Products Offered
        11.3.5 Sun Pharmaceuticals Recent Development
    11.4 Actavis Generics
        11.4.1 Actavis Generics Company Details
        11.4.2 Company Business Overview
        11.4.3 Actavis Generics Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Actavis Generics Imatinib Drug Products Offered
        11.4.5 Actavis Generics Recent Development
    11.5 Dr. Reddy's Laboratories
        11.5.1 Dr. Reddy's Laboratories Company Details
        11.5.2 Company Business Overview
        11.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Dr. Reddy's Laboratories Imatinib Drug Products Offered
        11.5.5 Dr. Reddy's Laboratories Recent Development
    11.6 Teva Pharmaceutical Industries Ltd.
        11.6.1 Teva Pharmaceutical Industries Ltd. Company Details
        11.6.2 Company Business Overview
        11.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Products Offered
        11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
    11.7 Sanofi S.A.
        11.7.1 Sanofi S.A. Company Details
        11.7.2 Company Business Overview
        11.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Sanofi S.A. Imatinib Drug Products Offered
        11.7.5 Sanofi S.A. Recent Development
    11.8 Cipla Inc.
        11.8.1 Cipla Inc. Company Details
        11.8.2 Company Business Overview
        11.8.3 Cipla Inc. Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Cipla Inc. Imatinib Drug Products Offered
        11.8.5 Cipla Inc. Recent Development
    11.9 Apotex Inc.
        11.9.1 Apotex Inc. Company Details
        11.9.2 Company Business Overview
        11.9.3 Apotex Inc. Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Apotex Inc. Imatinib Drug Products Offered
        11.9.5 Apotex Inc. Recent Development
    11.10 Mylan Pharms Inc.
        11.10.1 Mylan Pharms Inc. Company Details
        11.10.2 Company Business Overview
        11.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Mylan Pharms Inc. Imatinib Drug Products Offered
        11.10.5 Mylan Pharms Inc. Recent Development

12 Future Forecast
    12.1 Imatinib Drug Market Forecast by Regions
        12.1.1 Global Imatinib Drug Sales Forecast by Regions 2019-2025
        12.1.2 Global Imatinib Drug Revenue Forecast by Regions 2019-2025
    12.2 Imatinib Drug Market Forecast by Product
        12.2.1 Global Imatinib Drug Sales Forecast by Product 2019-2025
        12.2.2 Global Imatinib Drug Revenue Forecast by Product 2019-2025
    12.3 Imatinib Drug Market Forecast by End User
    12.4 North America Imatinib Drug Forecast
    12.5 Europe Imatinib Drug Forecast
    12.6 Asia Pacific Imatinib Drug Forecast
    12.7 Central & South America Imatinib Drug Forecast
    12.8 Middle East and Africa Imatinib Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Imatinib Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures Figure Imatinib Drug Product Picture Table Imatinib Drug Market Segments Table Key Manufacturers Imatinib Drug Covered Table Global Imatinib Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Imatinib Drug Sales Market Share by Product 2014-2025 Figure Tablets Product Picture Table Major Manufacturers of Tablets Figure Capsules Product Picture Table Major Manufacturers of Capsules Table Global Imatinib Drug Market Size Growth Rate by End User 2019-2025 (K Units) Figure Chronic myelogenous leukemia Figure Gastrointestinal stromal tumors Figure Others Figure Imatinib Drug Report Years Considered Figure Global Imatinib Drug Market Size 2014-2025 (Million US$) Figure Global Imatinib Drug Sales 2014-2025 (K Units) Table Global Imatinib Drug Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Imatinib Drug Sales by Regions 2014-2019 (K Units) Table Global Imatinib Drug Sales Market Share by Regions 2014-2019 Figure Global Imatinib Drug Sales Market Share by Regions 2014-2019 Figure 2018 Global Imatinib Drug Sales Market Share by Regions Table Global Imatinib Drug Revenue by Regions 2014-2019 (Million US$) Table Global Imatinib Drug Revenue Market Share by Regions 2014-2019 Figure Global Imatinib Drug Revenue Market Share by Regions 2014-2019 Figure 2018 Global Imatinib Drug Revenue Market Share by Regions Table Global Imatinib Drug Sales by Manufacturers (2014-2019) (K Units) Table Global Imatinib Drug Sales Share by Manufacturers (2014-2019) Figure Global Imatinib Drug Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Imatinib Drug Revenue by Manufacturers (2014-2019) (Million USD) Table Imatinib Drug Revenue Share by Manufacturers (2014-2019) Figure Imatinib Drug Value Share by Manufacturers in 2018 Table Key Manufacturers Imatinib Drug Price (2014-2019) (USD/Unit) Table Imatinib Drug Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Imatinib Drug Product Type Table Date of International Manufacturers Enter into Imatinib Drug Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Imatinib Drug Sales by Product (2014-2019) (K Units) Table Global Imatinib Drug Sales Share by Product (2014-2019) Figure Global Imatinib Drug Sales Market Share by Product (2014-2019) Figure Global Imatinib Drug Sales Market Share by Product in 2018 Table Global Imatinib Drug Revenue by Product (2014-2019) (Million US$) Table Global Imatinib Drug Revenue Share by Product (2014-2019) Figure Global Imatinib Drug Revenue Market Share by Product (2014-2019) Figure Global Imatinib Drug Revenue Market Share by Product in 2018 Table Imatinib Drug Price by Product 2014-2019 (USD/Unit) Table Global Imatinib Drug Sales by End User (2014-2019) (K Units) Table Global Imatinib Drug Sales Share by End User (2014-2019) Figure Global Sales Imatinib Drug Market Share by End User (2014-2019) Figure Global Sales Imatinib Drug Market Share by End User in 2018 Figure North America Imatinib Drug Sales Growth Rate 2014-2019 (K Units) Figure North America Imatinib Drug Revenue Growth Rate 2014-2019 (Million US$) Table North America Imatinib Drug Sales by Countries (2014-2019) (K Units) Table North America Imatinib Drug Sales Market Share by Countries (2014-2019) Figure 2018 North America Imatinib Drug Sales Market Share by Countries Table North America Imatinib Drug Revenue by Countries (2014-2019) (Million US$) Table North America Imatinib Drug Revenue Market Share by Countries (2014-2019) Figure 2018 North America Imatinib Drug Revenue Market Share by Countries Figure United States Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure United States Imatinib Drug Revenue Growth Rate (2014-2019) (K Units) Figure Canada Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Canada Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Mexico Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Table North America Imatinib Drug Sales by Product (2014-2019) (K Units) Table North America Imatinib Drug Sales Market Share by Product (2014-2019) Figure 2018 North America Imatinib Drug Market Share by Product Table North America Imatinib Drug Sales by End User (2014-2019) (K Units) Table North America Imatinib Drug Sales Market Share by End User (2014-2019) Figure 2018 North America Imatinib Drug Market Share by End User Figure Europe Imatinib Drug Sales Growth Rate 2014-2019 (K Units) Figure Europe Imatinib Drug Revenue Growth Rate 2014-2019 (Million US$) Table Europe Imatinib Drug Sales by Countries (2014-2019) (K Units) Table Europe Imatinib Drug Sales Market Share by Countries (2014-2019) Figure 2018 Europe Imatinib Drug Sales Market Share by Countries Table Europe Imatinib Drug Revenue by Countries (2014-2019) (Million US$) Table Europe Imatinib Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Imatinib Drug Revenue Market Share by Countries Figure Germany Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Germany Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure France Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure France Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure UK Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure UK Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Italy Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Russia Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Table Europe Imatinib Drug Sales by Product (2014-2019) (K Units) Table Europe Imatinib Drug Sales Market Share by Product (2014-2019) Figure 2018 Europe Imatinib Drug Market Share by Product Table Europe Imatinib Drug Sales by End User (2014-2019) (K Units) Table Europe Imatinib Drug Sales Market Share by End User (2014-2019) Figure 2018 Europe Imatinib Drug Market Share by End User Figure Asia Pacific Imatinib Drug Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Imatinib Drug Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Imatinib Drug Sales by Countries (2014-2019) (K Units) Table Asia Pacific Imatinib Drug Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Imatinib Drug Sales Market Share by Countries Table Asia Pacific Imatinib Drug Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Imatinib Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Imatinib Drug Revenue Market Share by Countries Figure China Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure China Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Japan Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Korea Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure India Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure India Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Australia Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Philippines Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Thailand Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Singapore Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Imatinib Drug Sales by Product (2014-2019) (K Units) Table Asia Pacific Imatinib Drug Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Imatinib Drug Market Share by Product Table Asia Pacific Imatinib Drug Sales by End User (2014-2019) (K Units) Table Asia Pacific Imatinib Drug Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Imatinib Drug Market Share by End User Figure Central & South America Imatinib Drug Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Imatinib Drug Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Imatinib Drug Sales by Countries (2014-2019) (K Units) Table Central & South America Imatinib Drug Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Imatinib Drug Sales Market Share by Countries Table Central & South America Imatinib Drug Revenue by Countries (2014-2019) (Million US$) Table Central & South America Imatinib Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Imatinib Drug Revenue Market Share by Countries Figure Brazil Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Brazil Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Argentina Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Imatinib Drug Sales by Product (2014-2019) (K Units) Table Central & South America Imatinib Drug Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Imatinib Drug Market Share by Product Table Central & South America Imatinib Drug Sales by End User (2014-2019) (K Units) Table Central & South America Imatinib Drug Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Imatinib Drug Market Share by End User Figure Middle East and Africa Imatinib Drug Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Imatinib Drug Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Imatinib Drug Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Imatinib Drug Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Imatinib Drug Sales Market Share by Countries Table Middle East and Africa Imatinib Drug Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Imatinib Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Imatinib Drug Revenue Market Share by Countries Figure GCC Countries Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Turkey Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure Egypt Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Imatinib Drug Sales Growth Rate (2014-2019) (K Units) Figure South Africa Imatinib Drug Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Imatinib Drug Sales by Product (2014-2019) (K Units) Table Middle East and Africa Imatinib Drug Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Imatinib Drug Market Share by Product Table Middle East and Africa Imatinib Drug Sales by End User (2014-2019) (K Units) Table Middle East and Africa Imatinib Drug Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Imatinib Drug Market Share by End User Table Novartis Company Details Table Novartis Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table Glenmark Pharmaceuticals Ltd. Company Details Table Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Glenmark Pharmaceuticals Ltd. Recent Development Table Sun Pharmaceuticals Company Details Table Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sun Pharmaceuticals Recent Development Table Actavis Generics Company Details Table Actavis Generics Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Actavis Generics Recent Development Table Dr. Reddy's Laboratories Company Details Table Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Dr. Reddy's Laboratories Recent Development Table Teva Pharmaceutical Industries Ltd. Company Details Table Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceutical Industries Ltd. Recent Development Table Sanofi S.A. Company Details Table Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi S.A. Recent Development Table Cipla Inc. Company Details Table Cipla Inc. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Cipla Inc. Recent Development Table Apotex Inc. Company Details Table Apotex Inc. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Apotex Inc. Recent Development Table Mylan Pharms Inc. Company Details Table Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Mylan Pharms Inc. Recent Development Table Global Imatinib Drug Sales Forecast by Regions 2019-2025 (K Units) Table Global Imatinib Drug Sales Market Share Forecast by Regions 2019-2025 Table Global Imatinib Drug Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Imatinib Drug Revenue Market Share Forecast by Regions 2019-2025 Table Global Imatinib Drug Sales Forecast by Product 2019-2025 (K Units) Table Global Imatinib Drug Sales Market Share Forecast by Product 2019-2025 Table Global Imatinib Drug Revenue Forecast by Product 2019-2025 (Million US$) Table Global Imatinib Drug Revenue Market Share Forecast by Product 2019-2025 Table Global Imatinib Drug Sales Forecast by End User 2019-2025 (K Units) Table Global Imatinib Drug Sales Market Share Forecast by End User 2019-2025 Figure North America Imatinib Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Imatinib Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Imatinib Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Imatinib Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Imatinib Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Imatinib Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Imatinib Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Imatinib Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Imatinib Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Imatinib Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Imatinib Drug Value Chain Table Imatinib Drug Customers List Table Imatinib Drug Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Automotive Bearings Market Insights, Forecast to 2025

A bearing is a machine element that constrains relative motion to only the desired motion, and reduces friction between moving parts. The design of the bearing may, for example, provide for free linear movement of the moving part or for free rotation...

Global Analog Switches Market Insights, Forecast to 2025

Analog switches are used to turn-on or turn-off signal in an electronic device. The Analog Switches market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this st...

Global Ethyl Ecetoacetate(CAS 141-97-9) Market Insights, Forecast to 2025

The organic compound Ethyl Ecetoacetate is the ethyl ester of acetoacetic acid. It is mainly used as a chemical intermediate in the production of a wide variety of compounds, such as amino acids, analgesics, antibiotics, antimalarial agents, antipyri...

Global Food Supplement Market Insights, Forecast to 2025

Food supplements are concentrated sources of nutrients taken as a dietary top-up. They include fish oils, which have been shown to benefit heart health, minerals like iron to help prevent anaemia, and a whole list of vitamins, from A to K. The globa...

Global Automotive Infotainment System Market Insights, Forecast to 2025

Modern infotainment systems have evolved to be the hub of many vehicle functions, and are no longer just a way to control the stereo or navigation system. In many vehicles, they also handle telephone and data communications, plus vehicle setup and HV...

New Pharmaceuticals and Healthcare Reports